Related references
Note: Only part of the references are listed.Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study
Kimberly A. Casalvieri et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
Hee-Don Chae et al.
Oncotarget (2020)
Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets
Kimberly A. Casalvieri et al.
DATA IN BRIEF (2020)
Defining the role of the RSK isoforms in cancer
Thibault Houles et al.
SEMINARS IN CANCER BIOLOGY (2018)
Design and synthesis of potent RSK inhibitors
Rama Jain et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Cyclin-Dependent Kinase (CDK) Inhibitors: Structure Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines
Christopher R. Coxon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Selective Targeting of RSK Isoforms in Cancer
Kimberly A. Casalvieri et al.
TRENDS IN CANCER (2017)
Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay
Lamis Hammoud et al.
STEM CELL REPORTS (2016)
Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner
Martin Roffe et al.
CELLULAR SIGNALLING (2015)
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
Rama Jain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Trifluoroacetic Acid in 2,2,2-Trifluoroethanol Facilitates SNAr Reactions of Heterocycles with Arylamines
Benoit Carbain et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Prediction of hydration free energies for the SAMPL4 diverse set of compounds using molecular dynamics simulations with the OPLS-AA force field
Oliver Beckstein et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2014)
Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers
Ida Aronchik et al.
MOLECULAR CANCER RESEARCH (2014)
Overcoming Resistance to Sonic Hedgehog Inhibition by Targeting p90 Ribosomal S6 Kinase in Pediatric Medulloblastoma
Mary Rose Pambid et al.
PEDIATRIC BLOOD & CANCER (2014)
The p90 RSK Family Members: Common Functions and Isoform Specificity
Romain Lara et al.
CANCER RESEARCH (2013)
Regulation and function of the RSK family of protein kinases
Yves Romeo et al.
BIOCHEMICAL JOURNAL (2012)
Paving the way for targeting RSK in cancer
Yves Romeo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation
Sumin Kang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The RSK family of kinases: emerging roles in cellular signalling
Rana Anjum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways
Rossana Zaru et al.
NATURE IMMUNOLOGY (2007)
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway
Sumin Kang et al.
CANCER CELL (2007)
A clickable inhibitor reveals context-dependent autoactivation of p90 RSK
Michael S. Cohen et al.
NATURE CHEMICAL BIOLOGY (2007)
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo
Gopal P. Sapkota et al.
BIOCHEMICAL JOURNAL (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types
BA Dümmler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)